Richette, Pascal http://orcid.org/0000-0003-2132-4074
Dalbeth, Nicola http://orcid.org/0000-0003-4632-4476
Article History
First Online: 26 April 2024
Competing interests
: P.R. received fees from Horizon. N.D. received fees from AstraZeneca, Novartis, Horizon, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, LG Chem, JPI, PTC Therapeutics, Protalix, Unlocked Labs, Hikma, Dexcel Pharma, Shanton Pharma and Avalo outside the submitted work.